← Browse by Condition
Medical Condition

musk mg

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06106672 Phase 1, Phase 2
Recruiting

Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis

Enrollment
54 pts
Location
United States
Sponsor
COUR Pharmaceutical Developmen...
View Trial →